News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) to Participate in the Rodman & Renshaw Annual Global Investment Conference


8/30/2012 10:02:05 AM

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Rodman & Renshaw Annual Global Investment Conference, being held September 10-11, 2012 at The Waldorf Astoria in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Monday, September 10 at 12:05 PM (ET). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® and the angioedema franchise, as well as the Licensing and Funded Research Program (LFRP).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES